Clinical Trial Update: Strict IGF-1 Control in Acromegaly [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating strict IGF-1 control in acromegaly has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acromegaly

Snippet

Sponsor: Unity Health Toronto | Conditions: Acromegaly | Phase 3 | Status: COMPLETED